fda vertex pharmaceuticals - Search News

Vertex Pharma Stock Surges

Hosted on MSN · 4h

Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

Seeking Alpha · 2h

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

USA TODAY on MSN · 4h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Daily Voice Tolland County CT on MSN55m

FDA Approves First Non-Opioid Painkiller In 20+ Years: 'A Historic Milestone'

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

6h

Optimistic Outlook for Vertex Pharmaceuticals: Strong Performance, New Approvals, and Promising Pipeline Drive Buy Rating

Analyst Michael Yee of Jefferies maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), retaining the price target of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results